153 related articles for article (PubMed ID: 33844442)
1. Transcriptomic Evaluation of Juvenile Localized Scleroderma Skin With Histologic and Clinical Correlation.
Schutt C; Mirizio E; Salgado C; Reyes-Mugica M; Wang X; Chen W; Grunwaldt L; Schollaert KL; Torok KS
Arthritis Rheumatol; 2021 Oct; 73(10):1921-1930. PubMed ID: 33844442
[TBL] [Abstract][Full Text] [Related]
2. Immunopathogenesis of Pediatric Localized Scleroderma.
Torok KS; Li SC; Jacobe HM; Taber SF; Stevens AM; Zulian F; Lu TT
Front Immunol; 2019; 10():908. PubMed ID: 31114575
[TBL] [Abstract][Full Text] [Related]
3. Single-Cell Transcriptome Analysis Identifies Subclusters with Inflammatory Fibroblast Responses in Localized Scleroderma.
Werner G; Sanyal A; Mirizio E; Hutchins T; Tabib T; Lafyatis R; Jacobe H; Torok KS
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37372943
[TBL] [Abstract][Full Text] [Related]
4. Juvenile Scleroderma-What has Changed in the Meantime?
Adrovic A; Sahin S; Barut K; Kasapcopur O
Curr Rheumatol Rev; 2018; 14(3):219-225. PubMed ID: 29692255
[TBL] [Abstract][Full Text] [Related]
5. Major histocompatibility complex class I and class II alleles may confer susceptibility to or protection against morphea: findings from the Morphea in Adults and Children cohort.
Jacobe H; Ahn C; Arnett FC; Reveille JD
Arthritis Rheumatol; 2014 Nov; 66(11):3170-7. PubMed ID: 25223600
[TBL] [Abstract][Full Text] [Related]
6. Genetic Signatures From RNA Sequencing of Pediatric Localized Scleroderma Skin.
Mirizio E; Liu C; Yan Q; Waltermire J; Mandel R; Schollaert KL; Konnikova L; Wang X; Chen W; Torok KS
Front Pediatr; 2021; 9():669116. PubMed ID: 34164359
[TBL] [Abstract][Full Text] [Related]
7. Clinical, Histologic, and Transcriptomic Evaluation of Sequential Fat Grafting for Morphea: A Nonrandomized Controlled Trial.
Liu J; Wang J; Zhang Q; Lu F; Cai J
JAMA Dermatol; 2024 Apr; 160(4):425-433. PubMed ID: 38324287
[TBL] [Abstract][Full Text] [Related]
8. DNA methylation patterns in juvenile systemic sclerosis and localized scleroderma.
Coit P; Schollaert KL; Mirizio EM; Torok KS; Sawalha AH
Clin Immunol; 2021 Jul; 228():108756. PubMed ID: 33992755
[TBL] [Abstract][Full Text] [Related]
9. Clinicohistopathological correlations in juvenile localized scleroderma: studies on a subset of children with hypopigmented juvenile localized scleroderma due to loss of epidermal melanocytes.
Sung JJ; Chen TS; Gilliam AC; McCalmont TH; Gilliam AE
J Am Acad Dermatol; 2011 Aug; 65(2):364-373. PubMed ID: 21570153
[TBL] [Abstract][Full Text] [Related]
10. Significantly increased CCL5/RANTES and CCR7 mRNA levels in localized scleroderma.
Gambichler T; Skrygan M; Labanski AA; Kolios AG; Altmeyer P; Kreuter A
Regul Pept; 2011 Oct; 170(1-3):4-6. PubMed ID: 21616095
[TBL] [Abstract][Full Text] [Related]
11. Muscle Expression of Type I and Type II Interferons Is Increased in Juvenile Dermatomyositis and Related to Clinical and Histologic Features.
Moneta GM; Pires Marafon D; Marasco E; Rosina S; Verardo M; Fiorillo C; Minetti C; Bracci-Laudiero L; Ravelli A; De Benedetti F; Nicolai R
Arthritis Rheumatol; 2019 Jun; 71(6):1011-1021. PubMed ID: 30552836
[TBL] [Abstract][Full Text] [Related]
12. Peripheral blood cytokine and chemokine profiles in juvenile localized scleroderma: T-helper cell-associated cytokine profiles.
Torok KS; Kurzinski K; Kelsey C; Yabes J; Magee K; Vallejo AN; Medsger T; Feghali-Bostwick CA
Semin Arthritis Rheum; 2015 Dec; 45(3):284-93. PubMed ID: 26254121
[TBL] [Abstract][Full Text] [Related]
13. Histopathologic differentiation between localized and systemic scleroderma.
Torres JE; Sánchez JL
Am J Dermatopathol; 1998 Jun; 20(3):242-5. PubMed ID: 9650695
[TBL] [Abstract][Full Text] [Related]
14. Interferon-gamma inducible protein-10 as a potential biomarker in localized scleroderma.
Magee KE; Kelsey CE; Kurzinski KL; Ho J; Mlakar LR; Feghali-Bostwick CA; Torok KS
Arthritis Res Ther; 2013; 15(6):R188. PubMed ID: 24499523
[TBL] [Abstract][Full Text] [Related]
15. Scleroderma in Children and Adolescents: Localized Scleroderma and Systemic Sclerosis.
Li SC
Pediatr Clin North Am; 2018 Aug; 65(4):757-781. PubMed ID: 30031497
[TBL] [Abstract][Full Text] [Related]
16. Compendium of skin molecular signatures identifies key pathological features associated with fibrosis in systemic sclerosis.
Moon SJ; Bae JM; Park KS; Tagkopoulos I; Kim KJ
Ann Rheum Dis; 2019 Jun; 78(6):817-825. PubMed ID: 30952646
[TBL] [Abstract][Full Text] [Related]
17. The localized scleroderma skin severity index and physician global assessment of disease activity: a work in progress toward development of localized scleroderma outcome measures.
Arkachaisri T; Vilaiyuk S; Li S; O'Neil KM; Pope E; Higgins GC; Punaro M; Rabinovich EC; Rosenkranz M; Kietz DA; Rosen P; Spalding SJ; Hennon TR; Torok KS; Cassidy E; Medsger TA;
J Rheumatol; 2009 Dec; 36(12):2819-29. PubMed ID: 19833758
[TBL] [Abstract][Full Text] [Related]
18. New Features for Measuring Disease Activity in Pediatric Localized Scleroderma.
Li SC; Li X; Pope E; Stewart K; Higgins GC; Rabinovich CE; O'Neil KM; Haines KA; Laxer RM; Punaro M; Jacobe H; Andrews T; Wittkowski K; Nyirenda T; Foeldvari I; Torok KS
J Rheumatol; 2018 Dec; 45(12):1680-1688. PubMed ID: 30219769
[TBL] [Abstract][Full Text] [Related]
19. Abatacept in the treatment of localized scleroderma: A pediatric case series and systematic literature review.
Kalampokis I; Yi BY; Smidt AC
Semin Arthritis Rheum; 2020 Aug; 50(4):645-656. PubMed ID: 32504991
[TBL] [Abstract][Full Text] [Related]
20. Single-cell transcriptome conservation in a comparative analysis of fresh and cryopreserved human skin tissue: pilot in localized scleroderma.
Mirizio E; Tabib T; Wang X; Chen W; Liu C; Lafyatis R; Jacobe H; Torok KS
Arthritis Res Ther; 2020 Nov; 22(1):263. PubMed ID: 33168063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
